---
title: DPT
description: 
published: true
date: 2026-01-29T16:29:10.346Z
tags: freeodwiki是一个开源项目，提供有关od、overdose、药物滥用、药物过量、吸毒、毒品、禁毒等话题的知识。
editor: markdown
dateCreated: 2026-01-24T19:38:35.061Z
---

# DPT

<mark>在本文档内，请谨慎点击不明链接，因为它们可能是移动后失效的相对路径！我的锅</mark>

[◀返回药物](./home.md)
>wiki主曾经过量一次喵，体验是剧烈变形......
>
>网购DPT所付出的代价不仅是钱，还是......(这可以称作为代价嘛?)
>
>           关于核查色胺类物质流向的情况报告
>      
>     禁毒支队： 
>
>       2025年10月15日，刑侦大队接支队核查情况报告称：辖区网名为“angel”的人员，2025年9月4日收取京东单号■■■■■■■■■■■■快递，内疑似有色胺类违禁药品。所留手机号码为：17284932629.经支队核查研判该手机号码为虚拟号码；人员身份无法落地。后要求■■禁毒中队通过当地信息管理，查明药品去向。经查，单号所留地址为■■■■■■■■■■■■■■■■■■■■■■■■■■■■■。
>       15日下午，我大队派员到菜鸟驿站和进行核查。经调取驿站内部视频发现：2025年9月4日16时27分，一女子取走该邮件。后经天网追踪、人脸识别，查明该女子叫■■■■■身份证号码■■■■■■■■■■■■■■■■■■
>     ......


| DPT ||
| --- |---|
| **化学命名** |
| 通用名 | *DPT, Dipropyltryptamine, The Light* |
| 取代名称 | *N,N-二丙基色胺* |
| 系统名 | *3-[2-(Dipropylamino)ethyl]indole* |
| **分类成员** |
| 精神活性分类 | *[迷幻剂](../文档/药物分类/迷幻剂.md)* |
| 化学分类 | *[色胺类物质](../文档/药物分类/色胺类物质.md)* |

### 给药途径与剂量

> **小贴士：** 由于每个人的体质、耐受性和新陈代谢都不同，建议从低剂量开始，慢慢摸索适合自己的量哦！[点我了解安全用药](../安全用药.md)。

#### ⇣ [吸食](../给药途径.md#吸食)

| 分级 | 剂量 |
| --- | --- |
| [阈值](../文档/药物剂量分类.md#阈值) | 10 mg |
| [轻度](../文档/药物剂量分类.md#轻度) | 15 - 20 mg |
| [常用](../文档/药物剂量分类.md#常用) | 20 - 50 mg |
| [强效](../文档/药物剂量分类.md#强效) | 50 - 100 mg |
| [重度](../文档/药物剂量分类.md#重度) | 100 mg + |

| 持续时间 | 时长 |
| --- | --- |
| [总时长](../文档/药效时长.md#总时长) | 30 - 90 分钟 |
| [起效](../文档/药效时长.md#起效) | 0 - 1 分钟 |
| [余效](../文档/药效时长.md#余效) | 2 - 4 小时 |

#### ⇣ [口服](../给药途径.md#口服)

| 分级 | 剂量 |
| --- | --- |
| [阈值](../文档/药物剂量分类.md#阈值) | 50 mg |
| [轻度](../文档/药物剂量分类.md#轻度) | 75 - 150 mg |
| [常用](../文档/药物剂量分类.md#常用) | 150 - 250 mg |
| [强效](../文档/药物剂量分类.md#强效) | 250 - 350 mg |
| [重度](../文档/药物剂量分类.md#重度) | 350 mg + |

| 持续时间 | 时长 |
| --- | --- |
| [总时长](../文档/药效时长.md#总时长) | 2 - 4 小时 |
| [起效](../文档/药效时长.md#起效) | 20 - 60 分钟 |
| [余效](../文档/药效时长.md#余效) | 2 - 3 小时 |

#### ⇣ [鼻吸](../给药途径.md#鼻吸)

| 分级 | 剂量 |
| --- | --- |
| [阈值](../文档/药物剂量分类.md#阈值) | 5 mg |
| [轻度](../文档/药物剂量分类.md#轻度) | 20 - 50 mg |
| [常用](../文档/药物剂量分类.md#常用) | 50 - 100 mg |
| [强效](../文档/药物剂量分类.md#强效) | 100 - 200 mg |
| [重度](../文档/药物剂量分类.md#重度) | 200 mg + |

| 持续时间 | 时长 |
| --- | --- |
| [总时长](../文档/药效时长.md#总时长) | 3 - 5 小时 |
| [起效](../文档/药效时长.md#起效) | 5 - 20 分钟 |
| [顶峰](../文档/药效时长.md#顶峰) | 30 - 45 分钟 |
| [余效](../文档/药效时长.md#余效) | 2 - 4 小时 |

> **[免责声明](../免责声明.md)：** 本站的[剂量](../给药剂量.md)信息来自用户和[网络资源](../网络.md)，仅供学习参考，不构成建议！请多方查证，安全第一喵！

| [相互作用](#危险的相互作用) | |
| --- | --- |

**N,N-二丙基色胺**（N,N-Dipropyltryptamine，也叫 **Dipropyltryptamine**、**DPT** 或 **"The Light"**）是一种比较小众的[色胺类物质](../文档/药物分类/色胺类物质.md)迷幻剂。它和 [DMT](./DMT.md) 是“亲戚”，致幻强度据说和 DMT 很像，但持续时间更长，体验也更不可预测，充满神秘感！

DPT 诞生于 1950 年，1973 年首次有了人类使用的记录，当时还被研究用来辅助治疗酗酒。后来也有高剂量用于癌症患者的高峰体验研究。它因为被美国“真光圣殿”选为主要圣礼而小有名气，这个组织会在仪式中用迷幻剂，称其为“上帝真正的血肉”。

DPT 常见的用法是[鼻吸](../给药途径.md#鼻吸)或[口服](../给药途径.md#口服)。很多人说鼻吸会让鼻子超级不舒服，起效又快，体验刺激到飞起！转成游离碱后还能[肌肉注射](../给药途径.md#肌肉注射)或[雾化吸入](../给药途径.md#雾化)。据说“真光圣殿”最喜欢吸食游离碱，老玩家还会喝 DPT 茶（不过这个说法还需要更多资料佐证喵~）。

关于 DPT 的药理、代谢和毒性数据很少，人类使用历史也不长。它曾作为 [DMT](./DMT.md) 的“灰色市场”替代品在[研究化学品](../文档/药物分类/研究化学品.md)市场流通。很多报告都说，如果没有丰富的[致幻剂](../文档/药物分类/致幻剂.md)经验，DPT 可能会有点“驾驭不住”。所以，强烈建议使用时一定要做好[伤害减少](../安全用药.md#致幻剂)措施，安全第一，体验才更美好喵！

--------------

* [DPT (维基百科)](https://en.wikipedia.org/wiki/Dipropyltryptamine)
* [DPT (Erowid Vault)](https://www.erowid.org/chemicals/dpt/dpt.shtml)
* [DPT (TiHKAL / Isomer Design)](https://isomerdesign.com/PiHKAL/read.php?domain=tk&id=9)

文献
----------

* Soskin, R.A., Grof, S., & Richards, W.A. (1973). Low doses of Dipropyltryptamine in psychotherapy. Archives of General Psychiatry, 28 6, 817-21.
* Richards, W. A., Rhead, J. C., DiLeo, F. B., Yensen, R., & Kurland, A. A. (1977). The peak experience variable in DPT-assisted psychotherapy with cancer patients. Journal of Psychedelic Drugs, 9(1), 1-10. <http://dx.doi.org/10.1080/02791072.1977.10472020>
* Grof, S., Soskin, R. A., Richards, W. A., & Kurland, A. A. (1972). DPT as an adjunct in psychotherapy of alcoholics. International Pharmacopsychiatry, 8(1), 104-115. PMID: 4150711
* Li, J., Rice, K.C., & France, C.P. (2007). Behavioral effects of dipropyltryptamine in rats: evidence for 5-HT1A and 5-HT2A agonist activity. Behavioural Pharmacology, 18 4, 283-8.

参考资料
----------

1. [↑](#cite_ref-1) Li, J. X.; Rice, K.; France, C. P. (2007). "Behavioral effects of dipropyltryptamine in rats: evidence for 5-HT1A and 5-HT2A agonist activity". *Behavioural Pharmacology*. **18** (4): 283–288. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1097/FBP.0b013e3281f19ca0](//doi.org/10.1097%2FFBP.0b013e3281f19ca0). [eISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number#Electronic_ISSN "wikipedia:International Standard Serial Number") [1473-5849](//www.worldcat.org/issn/1473-5849). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0955-8810](//www.worldcat.org/issn/0955-8810). [OCLC](http://en.wikipedia.org/wiki/OCLC "wikipedia:OCLC") [22170289](//www.worldcat.org/oclc/22170289). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier "wikipedia:PubMed Identifier") [17551320](//www.ncbi.nlm.nih.gov/pubmed/17551320).
2. [↑](#cite_ref-2) Grof, S.; Soskin, R. A.; Richards, W. A.; Kurland, A. A. (1973). "DPT as an Adjunct in Psychotherapy of Alcoholics". *International Pharmacopsychiatry*. **8** (1): 104–115. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1159/000467979](//doi.org/10.1159%2F000467979). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0020-8272](//www.worldcat.org/issn/0020-8272). [OCLC](http://en.wikipedia.org/wiki/OCLC "wikipedia:OCLC") [1753673](//www.worldcat.org/oclc/1753673). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier "wikipedia:PubMed Identifier") [4150711](//www.ncbi.nlm.nih.gov/pubmed/4150711).
3. [↑](#cite_ref-3) Richards, W. A.; Rhead, J. C.; Dileo, F. B.; Yensen, R.; Kurland, A. A. (1977). "The Peak Experience Variable in DPT-Assisted Psychotherapy with Cancer Patients". *Journal of Psychedelic Drugs*. **9** (1): 1–10. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1080/02791072.1977.10472020](//doi.org/10.1080%2F02791072.1977.10472020). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0022-393X](//www.worldcat.org/issn/0022-393X). [OCLC](http://en.wikipedia.org/wiki/OCLC "wikipedia:OCLC") [7565359](//www.worldcat.org/oclc/7565359).
4. [↑](#cite_ref-4) ["Temple of the True Inner Light"](http://psychede.tripod.com/). Retrieved January 9, 2020.
5. [↑](#cite_ref-5) Fantegrossi, W., Reissig, C., Katz, E., Yarosh, H., Rice, K., Winter, J. (January 2008). ["Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): Possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents"](https://linkinghub.elsevier.com/retrieve/pii/S0091305707002894). *Pharmacology Biochemistry and Behavior*. **88** (3): 358–365. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/j.pbb.2007.09.007](//doi.org/10.1016%2Fj.pbb.2007.09.007). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0091-3057](//www.worldcat.org/issn/0091-3057).
6. [↑](#cite_ref-6) Tribune, B. D. S., [*Carver County teen’s death puts spotlight on ease of purchasing synthetic drugs online*](https://www.startribune.com/carver-county-teen-s-death-puts-spotlight-on-ease-of-purchasing-synthetic-drugs-online/330344661/)
7. [↑](#cite_ref-7) Smith, D. A.; Bailey, J. M.; Williams, D.; Fantegrossi, W. E. (2014). ["Tolerance and Cross-Tolerance to Head Twitch Behavior Elicited by Phenethylamine- and Tryptamine-Derived Hallucinogens in Mice"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4309922). *Journal of Pharmacology and Experimental Therapeutics*. **351** (2): 485–491. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1124/jpet.114.219337](//doi.org/10.1124%2Fjpet.114.219337). [eISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number#Electronic_ISSN "wikipedia:International Standard Serial Number") [1521-0103](//www.worldcat.org/issn/1521-0103). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0022-3565](//www.worldcat.org/issn/0022-3565). [OCLC](http://en.wikipedia.org/wiki/OCLC "wikipedia:OCLC") [1606914](//www.worldcat.org/oclc/1606914). [PMC](http://en.wikipedia.org/wiki/PubMed_Central "wikipedia:PubMed Central") [4309922](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4309922) ![Freely accessible](https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/langen-gb-20px-Lock-green.svg.png "Freely accessible"). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier "wikipedia:PubMed Identifier") [25271256](//www.ncbi.nlm.nih.gov/pubmed/25271256).
8. [↑](#cite_ref-8) Talaie, H.; Panahandeh, R.; Fayaznouri, M. R.; Asadi, Z.; Abdollahi, M. (2009). ["Dose-independent occurrence of seizure with tramadol"](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3550327). *Journal of Medical Toxicology*. **5** (2): 63–67. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1007/BF03161089](//doi.org/10.1007%2FBF03161089). [eISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number#Electronic_ISSN "wikipedia:International Standard Serial Number") [1937-6995](//www.worldcat.org/issn/1937-6995). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1556-9039](//www.worldcat.org/issn/1556-9039). [OCLC](http://en.wikipedia.org/wiki/OCLC "wikipedia:OCLC") [163567183](//www.worldcat.org/oclc/163567183). [PMC](http://en.wikipedia.org/wiki/PubMed_Central "wikipedia:PubMed Central") [3550327](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3550327) ![Freely accessible](https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/langen-gb-20px-Lock-green.svg.png "Freely accessible"). [PMID](http://en.wikipedia.org/wiki/PubMed_Identifier "wikipedia:PubMed Identifier") [19415589](//www.ncbi.nlm.nih.gov/pubmed/19415589).
9. [↑](#cite_ref-9) ["Anlage NpSG"](https://www.gesetze-im-internet.de/npsg/anlage.html) (in German). Bundesministerium der Justiz und für Verbraucherschutz [Federal Ministry of Justice and Consumer Protection]. Retrieved December 10, 2019.
10. [↑](#cite_ref-10) ["Verordnung zur Änderung der Anlage des Neue-psychoaktive-Stoffe-Gesetzes und von Anlagen des Betäubungsmittelgesetzes"](http://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl119s1083.pdf) (PDF). *Bundesgesetzblatt Jahrgang 2019 Teil I Nr. 27* (in German). Bundesanzeiger Verlag. July 17, 2019. pp. 1083–1094. Retrieved January 1, 2020.
11. [↑](#cite_ref-11) ["§ 4 NpSG"](https://www.gesetze-im-internet.de/npsg/__4.html) (in German). Bundesministerium der Justiz und für Verbraucherschutz [Federal Ministry of Justice and Consumer Protection]. Retrieved December 10, 2019.
12. [↑](#cite_ref-12) ["Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem"](http://likumi.lv/doc.php?id=121086) (in Latvian). VSIA Latvijas Vēstnesis. November 10, 2005. Retrieved January 1, 2020.
13. [↑](#cite_ref-13) ["Schedule 1 Class A controlled drugs"](http://www.legislation.govt.nz/act/public/1975/0116/latest/whole.html#DLM436576). *"Reprint as at 13 August 2019: Misuse of Drugs Act 1975"*. Parliamentary Counsel Office. Retrieved January 7, 2020.
14. [↑](#cite_ref-14) ["31 nya substanser klassas som narkotika eller hälsofarlig vara"](https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2016/januari/31-nya-substanser-klassas-som-narkotika-eller-halsofarlig-vara) (in Swedish). Folkhälsomyndigheten [Public Health Agency of Sweden]. January 26, 2016. Retrieved January 1, 2020.
15. [↑](#cite_ref-15) ["Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien"](https://www.admin.ch/opc/de/classified-compilation/20101220/index.html) (in German). Bundeskanzlei [Federal Chancellery of Switzerland]. Retrieved January 1, 2020.
16. [↑](#cite_ref-16) ["Part I: Class A Drugs"](http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I). *"Misuse of Drugs Act 1971"*. UK Government. Retrieved January 7, 2020.
17. [↑](#cite_ref-17) ["Title XLVI: Chapter 893: Drug Abuse Prevention And Control"](http://leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=0800-0899/0893/0893.html). *The 2019 Florida Statutes*. The Florida Legislature. Retrieved January 10, 2020.
18. [↑](#cite_ref-18) <http://legislature.maine.gov/statutes/17-a/title17-Asec1102.html>
19. [↑](#cite_ref-19) ["Section 2-204 - Schedule I"](https://web.archive.org/web/20190709113340/http://www.oscn.net/applications/oscn/DeliverDocument.asp?CiteID=98866). *Oklahoma Statutes Citationized*. Oklahoma Judicial Center. January 11, 2019. Archived from [the original](http://www.oscn.net/applications/oscn/DeliverDocument.asp?CiteID=98866) on July 9, 2019. Retrieved January 10, 2020.